| 2/16/2016 | PP | Discovery Labs renews at-the-market equity sales agreement to 2019
|
| 7/22/2015 | PP | Discovery greenshoe exercised for $40.23 million public sale of units
|
| 7/17/2015 | PP | Discovery prices $34.98 million public sale of units at $0.60 per unit
|
| 7/16/2015 | PP | Discovery Laboratories to conduct public offering of equity units
|
| 10/31/2013 | PP | Discovery Labs prices $50 million public offering of stock at $2.00
|
| 10/30/2013 | PP | Discovery Laboratories to conduct public offering of its common shares
|
| 5/10/2013 | PP | Discovery Labs prices $14.25 million public offering of stock at $1.50
|
| 2/13/2013 | PP | Discovery Labs arranges $30 million 8.75% loan facility with Deerfield
|
| 2/13/2013 | PP | Discovery Labs secures $25 million through at-the-market agreement
|
| 8/10/2012 | PP | Discovery Labs terminates $15 million at-the-market deal with Lazard
|
| 3/16/2012 | PP | Discovery Labs prices $45 million public offering of common stock
|
| 3/15/2012 | PP | Discovery Laboratories to price public offering of its common shares
|
| 12/14/2011 | PP | Discovery Labs secures $15 million through at-the-market agreement
|
| 6/8/2011 | CVHYPF | Discovery Labs files $200 million shelf for preferreds, debt, stock
|
| 6/14/2010 | PP | New Issue: Discovery Labs negotiates $35 million equity facility with Kingsbridge
|
| 6/14/2010 | PP | Market Commentary: Discovery Labs inks three-year deal; Chindex selling stock to Fosun; Timminco wraps stock sale
|
| 5/8/2009 | PP | New Issue: Discovery Laboratories announces $11.34 million registered direct offering of stock
|
| 12/15/2008 | PP | Market Commentary: TimberWest eyes C$100 million; Huntsman settles suits; Discovery Labs adds line
|
| 12/15/2008 | PP | New Issue: Discovery arranges $25 million equity facility with Kingsbridge
|
| 6/13/2008 | CVHY | Discovery files $150 million shelf registration
|
| 5/27/2008 | PP | New Issue: Discovery negotiates $60 million equity financing facility with Kingsbridge
|
| 5/27/2008 | PP | Market Commentary: Guaranty, Standard Pacific land new investors; Helio raises for project; Discovery Labs gets equity facility
|
| 12/7/2007 | PP | New Issue: Discovery Laboratories announces $25 million direct placement of stock
|
| 12/7/2007 | PP | Market Commentary: Epic Energy Resources pockets $26.85 million from stock and notes with warrants
|
| 4/27/2007 | SS | Market Commentary: GE gains on break-up theory; Applebee's rises; Universal Power retreats; Delta Air slides
|
| 4/3/2007 | PP | New Issue: Discovery Laboratories secures $30.2 million from stock sale
|
| 4/3/2007 | PP | Market Commentary: PolyMet stock gains 10% on $41.25 million private placement; ANTs raises $13 million
|
| 11/22/2006 | PP | New Issue: Discovery Laboratories wraps $10 million placement of stock
|
| 11/22/2006 | PP | Market Commentary: Anesiva secures $45 million from direct stock sale; Discovery Labs pockets $10 million from PIPE
|
| 10/26/2006 | BT | Market Commentary: Achillion gains on debut; Cadence slips; DOV Pharma nosedives; Celgene better; Renovis falls 76%
|
| 10/26/2006 | BT | Discovery Labs amends $8.5 million loan financing from Quintiles
|
| 10/17/2006 | BT | Market Commentary: Icos gains 16% on Lilly buyout; Millennium forfeits AnorMED; InterMune rises 25%; OSI better
|
| 10/12/2006 | BT | Market Commentary: Genzyme gets AnorMED nod but hurt by 3Q; Nabi up 6% on asset sale; Trimeris off 13% on warning
|
| 10/10/2006 | BT | Market Commentary: AnorMED gains 5% as Genzyme bests Millennium bid; DOV sinks 9% on hiring HSBC, up after close
|
| 9/22/2006 | BT | Market Commentary: Amgen leads sector lower; Dyax gains on Kos' loss; Oscient rises; Gene Logic up; Discovery Labs off
|
| 9/14/2006 | BT | Market Commentary: Threshold, Discovery Labs gain on widespread deal speculation; Curis better; Genzyme gains 3%
|
| 9/11/2006 | BT | Market Commentary: Genentech falls on Avastin delay; Vertex pitches $300 million deal; OSI off 2%; Genitope loses 5%
|
| 9/8/2006 | BT | Market Commentary: Discovery Labs spikes on buyout buzz; Cell Genesys loses 5% on bought deal; Oscient buffeted
|
| 8/10/2006 | BT | Market Commentary: ImClone slammed after it ditches deal search; Oscient rises 12.5%; Vical sinks
|
| 7/31/2006 | BT | Jefferies puts Discovery Labs on hold
|
| 7/31/2006 | BT | Market Commentary: ImClone off 4%, Repligen soars; Viragen slides, Napo debuts up; Pozen gains; Novavax up 12.5%
|
| 7/28/2006 | BT | Discovery Labs second-quarter net loss rises to $14.7 million from net loss of $9.8 million
|
| 7/24/2006 | BT | Market Commentary: Genitope falls 12%; Micromet off; Oscient up; DepoMed dives; Atricure off; Discovery Labs rises 10%
|
| 6/28/2006 | BT | Discovery Labs says it has identified new, undisclosed indication for Surfaxin
|
| 6/27/2006 | BT | Discovery Labs making progress on surfactant manufacturing remediation
|
| 6/27/2006 | BT | Market Commentary: Insmed drops 11%; Vasogen up slightly; Anadys falls more; DOV, Discovery Labs up; Genelabs gains
|
| 6/20/2006 | BT | Discovery Labs hires Jefferies & Co. to pursue strategic alternatives
|
| 6/20/2006 | BT | Market Commentary: Discovery Labs bounces; Biomira looks for acquisitions; Curis hits new low; Human Genome higher
|
| 6/15/2006 | BT | Discovery's Surfaxin granted orphan-drug designation to treat premature infants
|
| 6/15/2006 | BT | Market Commentary: Nabi rises on renewed pressure; Anadys dives 18%; Discovery Labs surges 26%; Auxilium off
|
| 6/7/2006 | BT | Jefferies puts Discovery Labs on hold
|
| 6/7/2006 | BT | Market Commentary: Antigenics up 11% on data; Discovery Labs dives 19%; Incyte up; VaxGen slides
|
| 5/16/2006 | BT | Market Commentary: Neurocrine, DOV dive; Novavax, Generex dive amid noise of exits; Adventrx slips modestly on deal
|
| 5/11/2006 | BT | Jefferies keeps Discovery Labs at hold
|
| 5/9/2006 | BT | Discovery Laboratories ends phase 2 trial of Surfaxin early
|
| 5/4/2006 | BT | Discovery Labs cuts staff by 34%, reorganizes management in response to Surfaxin delay
|
| 4/28/2006 | BT | Market Commentary: Neurocrine drops as data digested; Somaxon higher as buyers step in; Spectranetics up; Sonus soars 8%
|
| 4/26/2006 | BT | Discovery Labs reinstated at hold by Jefferies
|
| 4/26/2006 | BT | Market Commentary: Inspire trial launch brings buyers; Avigen players hopeful; Applera units mixed; LifeCell lifted 15%
|
| 4/25/2006 | BT | Market Commentary: Serologicals, Millipore both up; other services names dip; DOV, Discovery dive; Neurocrine off
|
| 4/24/2006 | BT | Discovery Labs anticipates 'significant' delay in Surfaxin approval
|
| 4/24/2006 | BT | Market Commentary: DOV, Discovery Labs off huge after close; 3 deals emerge; GW up big; Ariad off on Amgen suit
|
| 4/20/2006 | BT | Jefferies has Discovery Labs at buy
|
| 4/20/2006 | BT | Market Commentary: MedImmune dives 12%; Cubist gains over 9%; Discovery Labs, Dynavax rise on financing deals
|
| 4/20/2006 | PP | Market Commentary: Jumping oil prices will likely spark energy offerings, sellsiders say; O2Diesel prices two PIPEs
|
| 4/19/2006 | BTPP | New Issue: Discovery Laboratories receives equity line for up to $50 million
|
| 4/19/2006 | PP | Market Commentary: Discovery Labs procures $50 million equity line; Alteon plans $2.5 million unit sale
|
| 4/13/2006 | BT | Discovery Labs kept at buy by Jefferies
|
| 4/13/2006 | BT | Market Commentary: Adolor ends better but off highs; ArQule off amid internal changes; Hemispherx spikes 7% on PIPE
|
| 4/12/2006 | BT | Jefferies keeps Discovery Labs at buy
|
| 4/12/2006 | BT | Market Commentary: Vanda, Targacept tank on debut; Omrix IPO in limbo; Novavax, KOS climb; Discovery soars after hours
|
| 4/6/2006 | BT | Market Commentary: Amgen a drag on biotech sector; Medarex follow-on seen on deck; Oscient up on PIPE after-hours
|
| 4/5/2006 | BT | Discovery Labs gets second approvable letter for Surfaxin
|
| 4/5/2006 | BT | Discovery Labs at buy by Jefferies
|
| 4/5/2006 | BT | Market Commentary: Allergan rolls out $700 million note; Discovery falls on FDA request for more data; Human Genome up
|
| 3/31/2006 | BT | Jefferies rates Discovery Labs at buy
|
| 3/30/2006 | BT | Discovery Labs says surfactant replacement respiratory therapy effective in 50% of patients
|
| 3/3/2006 | BT | Discovery Labs rated at buy by Jefferies
|
| 2/24/2006 | BT | Jefferies puts Discovery Labs at buy
|
| 1/26/2006 | BT | Discovery Labs' Surfaxin receives FDA fast track designation for bronchopulmonary dysplasia
|
| 1/26/2006 | BT | Jefferies reiterates Discovery Labs at buy
|
| 1/4/2006 | BT | Discovery Labs reiterated by Jefferies at buy
|
| 12/30/2005 | BT | Discovery to acquire Laureate's manufacturing operations to make infant respiratory drug Surfaxin
|
| 12/14/2005 | PP | Market Commentary: NGAS raises $37 million in note sale; biotech deals continue to dominate PIPE offerings
|
| 12/14/2005 | BTPP | New Issue: Discovery Labs to close $20.01 million direct placement of shares
|
| 12/12/2005 | BT | Discovery Labs reiterated by Jefferies at buy
|
| 11/17/2005 | BT | Jefferies maintains Discovery Labs buy
|
| 11/15/2005 | BT | Jefferies initiates Discovery Labs at buy
|
| 10/27/2005 | BTPP | New Issue: Discovery Laboratories to raise $4.47 million in direct placement of stock
|
| 10/21/2005 | BT | Market Commentary: Electro-Optical delays IPO again; Jerini IPO scheduled for Oct. 24 week; Affymetrix off; Cephalon higher
|
| 10/21/2005 | BT | Discovery Labs gets Surfaxin approval letter from FDA
|
| 10/11/2005 | BTCV | Discovery Laboratories files $100 million shelf
|
| 8/1/2005 | BT | Market Commentary: Anadys, Ariad, Nastech offerings join ZymoGenetics for this week; Amgen, Abgenix up on fast track
|
| 6/15/2005 | BT | Mylan Labs upgraded by Lehman
|
| 2/22/2005 | PP | New Issue: Discovery Labs extends $26.5 million offering for additional $2.6 million
|
| 2/22/2005 | PP | Market Commentary: Private placement activity remains mostly light; Level 3 Communications raises $880 million
|
| 2/18/2005 | PP | New Issue: Discovery Laboratories arranges $26.5 million direct placement of stock
|
| 2/18/2005 | PP | Market Commentary: Private placement volume stalls; Discovery Laboratories plans $26.5 million offering
|
